about
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candi...
Read More
27.45
0.08
(0.29%)
12,928.5
XNAS Volume
XNAS 26 Aug, 2026 9:36 AM (EDT)
Not Eligible
Expensive Valuation
No Score Avaliable
Apnimed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..